1. Home
  2. OFG vs MIRM Comparison

OFG vs MIRM Comparison

Compare OFG & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OFG Bancorp

OFG

OFG Bancorp

HOLD

Current Price

$40.79

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$79.53

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFG
MIRM
Founded
1964
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
4.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
OFG
MIRM
Price
$40.79
$79.53
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$45.75
$92.45
AVG Volume (30 Days)
249.8K
809.5K
Earning Date
01-22-2026
11-04-2025
Dividend Yield
2.92%
N/A
EPS Growth
6.55
N/A
EPS
4.40
N/A
Revenue
$624,004,000.00
$471,794,000.00
Revenue This Year
N/A
$53.78
Revenue Next Year
$1.02
$19.91
P/E Ratio
$9.35
N/A
Revenue Growth
N/A
53.66
52 Week Low
$33.15
$36.88
52 Week High
$46.11
$82.58

Technical Indicators

Market Signals
Indicator
OFG
MIRM
Relative Strength Index (RSI) 43.31 63.35
Support Level $41.75 $77.99
Resistance Level $42.44 $82.58
Average True Range (ATR) 0.66 3.21
MACD -0.16 1.07
Stochastic Oscillator 2.61 86.72

Price Performance

Historical Comparison
OFG
MIRM

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: